Led by Dr Ngo Thi Hoa, OUCRU researchers are proud to be involved in HECTOR - an interdisciplinary, multi-national research consortium which is investigating the genetic factors that contribute to antobiotic resistance. Results of this collaborative project will shed light on genetic factors of E.coli.
A letter in Nature by Snow et al. contributes significant insight into the complex, multifaceted interactions affecting malaria transmission rates in Africa over the past 115 years. The analysis exposes the limitations of the current malaria-control arsenal – not least of which are large gaps in the data.
International Open Access Week this year is 23-29 October. The theme is “open in order to…”, and is an invitation to answer the question of what concrete benefits can be realised by making scholarly outputs openly available. Join the online discussion on the benefits of open research with the hashtag #OpenInOrder
On 15 Oct, the Bangladesh GroupMappers held their first work workshop at the Cadet College Club, Dhaka. About 20 volunteer GroupMappers attended the workshop, which was led by MORU Epidemiology GIS Specialist Sazid Ibna Zaman, with support from Study Coordinator Didar Uddin, Dr. Ipsita Sinha and Richard Maude, Head of Epidemiology. GroupMappers ...
Congratulations to Professor Sir Nick White, elected to the National Academy of Medicine (US). Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
Work at the Cambodia Oxford Medical Research Unit (COMRU) and Angkor Hospital for Children (AHC) has highlighted the importance of melioidosis, infection by the soil-dwelling bacterium Burkholderia pseudomallei, as a cause of severe illness in Cambodian children (P Turner et al and Pagnarith et al).
A new Oxford University collaboration between the BDI and the Centre for Tropical Medicine and Global Health will support understanding and action around one of the world’s biggest health threats, drug-resistant infections.
Despite unprecedented decline since 2000, progress has stalled. A paper published in Nature today describes 115 years of malaria data collected in Africa by Professor Bob Snow. This article gives the most detailed picture yet of where efforts to control malaria infection are being won and lost across the continent.
The world’s number-one treatment for malaria is on the brink of failure because of a new strain of drug-resistant parasites — unless health policymakers take action. Professor Sir Nicholas White says that the mosquito-borne parasite responsible for severe malaria is now showing resistance to the prime treatment, Artemisinin Combination Therapy (ACT), across South-East Asia. If this resistance jumps to Africa, he warns, the tragedy will be on a massive scale.
A new typhoid vaccine for both adults and children has been proven by Oxford researchers to be safe and effective in preventing the disease. Professor Brian Angus participated in this study.